With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and ...

Tandem Diabetes Care issued a voluntary correction for an insulin pump model due to a speaker malfunction that disrupts communication with glucose monitoring systems, potentially causing high blood ...

Diabetes is increasingly affecting children, necessitating early detection for effective management. Type 1, an autoimmune ...

You don’t just naturally have “fast” or “slow” metabolism, as we once assumed. “The empowering part,” says Means, “is that there is so much we can do to improve our mitochondrial function.” According ...

Polycystic Ovary Syndrome (PCOS), affecting 10% of reproductive-age women, is linked to increased cardiovascular disease risk ...

Topline results from CATT1 Phase 3 trial expected in second half of 2026. HIGH POINT, NC, USA I August 07, 2025 I vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceuti ...

scPharmaceuticals’ management will host a conference call and webcast to review the Company’s second quarter 2025 results today, Thursday, August 7, at 4:30 p.m. ET. A link to the live webcast can be ...

KIMMTRAK® (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 ...